name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
MP:0004023 abnormal chromosome number 78 6 15.2 8.98 2.4e-06 0.00031 18.6 6.25 46
MP:0003111 abnormal cell nucleus morphology 172 8 9.18 7.73 2e-06 0.00031 11.3 4.5 25.1
MP:0003077 abnormal cell cycle 301 10 6.56 7 2e-06 0.00031 8.3 3.64 17.2
MP:0004046 abnormal mitosis 141 7 9.8 7.51 6.1e-06 6e-04 11.9 4.41 27.4
MP:0004024 aneuploidy 59 5 16.7 8.65 1.1e-05 0.00086 20.2 6.01 53.8
MP:0009762 abnormal mitotic spindle assembly checkpoint 10 3 59.2 13.1 1.4e-05 0.00094 89.3 14.4 404
MP:0013293 embryonic lethality prior to tooth bud stage 788 13 3.26 4.73 1e-04 0.0049 4.17 2.01 8.15
MP:0001672 abnormal embryo development 1018 15 2.91 4.61 9.2e-05 0.0049 3.84 1.93 7.34
MP:0013292 embryonic lethality prior to organogenesis 717 12 3.3 4.58 0.00017 0.0076 4.15 1.95 8.22
MP:0002835 abnormal cranial suture morphology 61 4 12.9 6.68 0.00024 0.0096 15 3.77 43.2
MP:0004025 polyploidy 27 3 21.9 7.77 0.00033 0.011 26.1 4.86 90.9
MP:0002132 abnormal respiratory system morphology 901 13 2.85 4.17 0.00038 0.011 3.59 1.73 7.01
MP:0004196 abnormal prenatal growth/weight/body size 1147 15 2.58 4.08 0.00035 0.011 3.35 1.68 6.4
MP:0005380 embryo phenotype 1722 19 2.18 3.87 0.00039 0.011 3 1.58 5.58
MP:0004979 abnormal neuronal precursor cell number 79 4 10 5.73 0.00066 0.012 11.3 2.89 32.4
MP:0008019 increased liver tumor incidence 135 5 7.31 5.27 0.00057 0.012 8.33 2.53 21.5
MP:0010297 increased hepatobiliary system tumor incidence 137 5 7.21 5.22 0.00061 0.012 8.2 2.49 21.2
MP:0010298 increased respiratory system tumor incidence 138 5 7.15 5.2 0.00063 0.012 8.14 2.47 21
MP:0008014 increased lung tumor incidence 138 5 7.15 5.2 0.00063 0.012 8.14 2.47 21
MP:0002018 increased malignant tumor incidence 378 8 4.18 4.5 0.00055 0.012 4.91 1.97 10.8
MP:0008762 embryonic lethality 1763 19 2.13 3.75 0.00053 0.012 2.91 1.53 5.42
MP:0000350 abnormal cell proliferation 966 13 2.66 3.88 0.00075 0.013 3.32 1.6 6.48
MP:0006092 abnormal olfactory sensory neuron morphology 37 3 16 6.53 0.00084 0.014 18.4 3.49 62.2
MP:0009760 abnormal mitotic spindle morphology 40 3 14.8 6.24 0.0011 0.017 16.9 3.22 56.7
MP:0003331 increased hepatocellular carcinoma incidence 90 4 8.77 5.29 0.0011 0.017 9.89 2.52 28.1
MP:0004100 abnormal spinal cord interneuron morphology 42 3 14.1 6.07 0.0012 0.018 16 3.06 53.5
MP:0001001 abnormal chemoreceptor morphology 44 3 13.5 5.91 0.0014 0.018 15.3 2.92 50.8
MP:0004948 abnormal neuronal precursor proliferation 95 4 8.31 5.11 0.0013 0.018 9.34 2.38 26.5
MP:0001176 abnormal lung development 165 5 5.98 4.61 0.0014 0.018 6.75 2.06 17.4
MP:0002884 abnormal pharyngeal arch morphology 165 5 5.98 4.61 0.0014 0.018 6.75 2.06 17.4
MP:0006204 embryonic lethality before implantation 168 5 5.88 4.55 0.0015 0.019 6.62 2.02 17
MP:0014134 abnormal embryo morphology 1333 15 2.22 3.44 0.0017 0.021 2.81 1.41 5.37
MP:0010273 increased classified tumor incidence 571 9 3.11 3.72 0.002 0.024 3.65 1.55 7.74
MP:0008866 chromosomal instability 112 4 7.05 4.6 0.0024 0.025 7.85 2.01 22.2
MP:0010094 abnormal chromosome stability 114 4 6.93 4.54 0.0026 0.025 7.71 1.98 21.8
MP:0010279 increased gastrointestinal tumor incidence 115 4 6.87 4.52 0.0026 0.025 7.64 1.96 21.6
MP:0003115 abnormal respiratory system development 188 5 5.25 4.2 0.0025 0.025 5.88 1.8 15.1
MP:0020188 abnormal classified tumor incidence 578 9 3.07 3.67 0.0021 0.025 3.61 1.53 7.63
MP:0002020 increased tumor incidence 706 10 2.8 3.54 0.0024 0.025 3.31 1.46 6.83
MP:0002088 abnormal embryonic growth/weight/body size 966 12 2.45 3.4 0.0025 0.025 2.97 1.4 5.89
MP:0000428 abnormal craniofacial morphology 1095 13 2.34 3.38 0.0024 0.025 2.88 1.39 5.62
MP:0005382 craniofacial phenotype 1099 13 2.34 3.36 0.0025 0.025 2.87 1.38 5.6
MP:0010274 increased organ/body region tumor incidence 606 9 2.93 3.51 0.003 0.027 3.42 1.45 7.25
MP:0006208 lethality throughout fetal growth and development 504 8 3.13 3.51 0.0035 0.031 3.61 1.45 7.9
MP:0013152 abnormal organ/body region tumor incidence 622 9 2.86 3.42 0.0035 0.031 3.33 1.41 7.05
MP:0008789 abnormal olfactory epithelium morphology 62 3 9.55 4.82 0.0037 0.032 10.6 2.05 34.5
MP:0004045 abnormal cell cycle checkpoint function 63 3 9.4 4.77 0.0039 0.032 10.4 2.01 33.9
MP:0000352 decreased cell proliferation 515 8 3.07 3.44 0.0039 0.032 3.53 1.42 7.71
MP:0010292 increased alimentary system tumor incidence 131 4 6.03 4.14 0.0042 0.033 6.67 1.71 18.7
MP:0002038 increased carcinoma incidence 306 6 3.87 3.64 0.0042 0.033 4.36 1.5 10.4
MP:0009967 abnormal neuron proliferation 133 4 5.94 4.09 0.0045 0.035 6.56 1.69 18.4
MP:0013500 abnormal fibroblast apoptosis 69 3 8.58 4.51 0.0051 0.038 9.46 1.83 30.7
MP:0011094 embryonic lethality before implantation, complete penetrance 143 4 5.52 3.89 0.0058 0.042 6.08 1.56 17.1
MP:0011099 lethality throughout fetal growth and development, complete penetrance 326 6 3.63 3.45 0.0057 0.042 4.07 1.4 9.75
MP:0002784 abnormal Sertoli cell morphology 74 3 8 4.32 0.0061 0.043 8.79 1.71 28.5
MP:0002019 abnormal tumor incidence 805 10 2.45 3.08 0.0061 0.043 2.87 1.27 5.91
MP:0002687 oligozoospermia 234 5 4.22 3.56 0.0063 0.044 4.68 1.43 12
MP:0005388 respiratory system phenotype 1374 14 2.01 2.9 0.0065 0.044 2.46 1.21 4.73
MP:0005499 abnormal olfactory system morphology 77 3 7.69 4.21 0.0069 0.045 8.43 1.64 27.3
MP:0002166 altered tumor susceptibility 819 10 2.41 3.02 0.0069 0.045 2.81 1.24 5.8
MP:0009781 abnormal preimplantation embryo development 78 3 7.59 4.17 0.0071 0.046 8.32 1.62 26.9
MP:0001701 incomplete embryo turning 80 3 7.4 4.1 0.0076 0.048 8.1 1.58 26.1
MP:0012431 increased lymphoma incidence 245 5 4.03 3.43 0.0077 0.048 4.46 1.36 11.4
MP:0010942 abnormal respiratory epithelium morphology 247 5 4 3.41 0.0079 0.049 4.42 1.35 11.3
